Home Your basket
• Pulsatile tinnitus and ve...
   Price 8.50 €
• A study of consonant inte...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Optimizing vocal efficien...
   Price 8.50 €
• Pneumatization (concha bu...
   Price 8.50 €
• Primary sub-mandibular gl...
   Price 8.50 €
• Management of cerebellopo...
   Price 10.50 €
• A perceptual study of the...
   Price 8.50 €
• Management of cervical ce...
   Price 10.50 €
• Side effects and patients...
   Price 10.50 €
• Allergic rhinitis...
   Price 8.50 €
• The relationship between ...
   Price 5.50 €
• The European Evaluation o...
   Price 8.50 €
• Laryngeal cryptococcosis ...
   Price 8.50 €
• Advantages of combined th...
   Price 10.50 €
• Isolated tracheo-œsophage...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Middle ear adenoma / carc...
   Price 8.50 €
• A survey of current wound...
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Saddle nose surgery: Long...
   Price 10.50 €
• Herniation of the temporo...
   Price 12.50 €
• Vibration induced nystagm...
   Price 10.50 €
• Cervical surgical emphyse...
   Price 5.50 €
• ...
   Price 5.50 €
• Aspects of voice quality ...
   Price 5.50 €
• Comparative study using A...
   Price 10.50 €
• Role of [18]-FDG PET/CT i...
   Price 10.50 €
• Nasal tumours of the thre...
   Price 10.50 €
• Acceptability of topical ...
   Price 5.50 €

Total Order 252.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 1999 o

CERVICO-FACIAL CARCINOLOGY

Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence ?


Authors : G. Dolivet, P. Colosetti, J. L. Merlin, Cl. Depardieu, M. Lapeyre, E. Wattel, J. Sarini, J. Ton Van, L. Geoffrois, Ph. Lagarde (Vandoeuvre les Nancy)

Ref. : Rev Laryngol Otol Rhinol 1999;120,1:5-12.

Article published in french



Summary : The study of epidemiology and of the carcinogenesis in epidermoid carcinomas of the upper aerodigestive tract shows that their occurrence is not random. Tobacco abuse plays a major role, especially because of benzopyrene, mutagen of the P53 gene, however it is associated with many other potentiating factors : alcohol, metals, hydrocarbures, virus, food, climate, genetic fragility that create genetic lesions at the origin of carcinogenesis. The latter occurs as "field cancerization" with multiple alterations of the mucosa and general attack of the control systems of the differentiation, growth and cell apoptosis which usually protect the cell against the phenomena of carcinogenesis. The P53 protein gene, retinoid receptors as well as the system of detoxifying glutathion S transferase are modified at the very early stage of these diseases, these abnormalities can be logically related to epidemiological data. These date lead us therefore to imagine complementary specific reverting therapies of induced genetic abnormalities, through the reexpression of non mutated gene encoding P53 protein and the use of retinoid. These various modalities are reported hereafter.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE